AMLN/Takeda officially dump Symlin + Metreleptin obesity program: http://finance.yahoo.com/news/Amylin-and-Takeda-Discontinue-prnews-2389602892.html?x=0&.v=1 Not surprising given the safety problem encountered five months ago (#msg-60998172).